Quin Wills

Selvedge Innovation LLP (Selvedge Venture) is a venture capital firm founded in 2019 by Alasdair Thong and Robert Thong. The firm is headquartered in London, United Kingdom.

Genomics England Ltd. runs and delivers 100,000 genomes project. Its flagship project sequences 100,000 genomes from NHS patients with a rare disease and their families, and patients with cancer. The company was founded by Jeremy Hunt on July 5, 2013 and is headquartered in London, the United Kingdom.

Part of Immunocore Holdings Plc, Immunocore Ltd. is a British commercial-stage biotechnology company that develops and commercializes transformative medicines to address unmet needs in cancer, infection, and autoimmune disease. The company is based in Oxon, UK. The company has a robust pipeline of wholly owned and partnered programs to address a broad spectrum of disease indications, built on their proprietary soluble TCR bi-specific Immtac® platform. The company was founded in 2007, and the CEO is Bahija Jallal.

Tessellate Bio BV is a Dutch preclinical stage biotechnology company that focuses on discovering and developing precision oncology medicines. The company is based in Naarden, the Netherlands. The company's mission is to turn cancer patients into cancer survivors by targeting unexplored or difficult to drug pathways beyond HRD. The company is also developing companion diagnostics, including a potentially diagnostic to detect ALT positive cancers. Led by an experienced team of drug hunters, Tessellate Bio is building a pipeline of first-in-class medicines based on cutting-edge research. The company was founded by Hilda A. Pickett and the CEO is Andree Blaukat.

Levicept Ltd. develops a biological therapy for the treatment of osteoarthritis and chronic pain. Its treatments include p75NTR-Fc and LEVI-04. The company was founded by Simon Lempriere Westbrook on August 23, 2012 and is headquartered in Sandwich, the United Kingdom.

Medicxi Ventures (Jersey) Ltd. (Medicxi) is an independent venture capital firm founded in 2016 by Francesco de Rubertis, Michèle Ollier, and Kevin S. Johnson. The firm is headquartered in London.

Luminous Ventures Ltd. (Luminous Ventures) is an Independent Private Equity/Venture Capital firm founded in 2018 by Lomax Blois. The firm is headquartered in London.

Multiomic Health Ltd. is a British AI-enabled drug discovery company that focuses on chronic multi-factorial diseases, particularly metabolic syndrome-related conditions. Multiomic Health is based in London, UK. The company partners with research institutions, healthcare providers, and healthtech companies to source de-identified patient data and samples. Multiomic's MOHSAIC® platform combines integrated multi-omics analysis and computational systems biology modeling with targeted wet laboratory experiments to originate novel precision therapeutic concepts. The company subsequently partners with established biopharma companies to take its therapeutic concepts into clinical trial programs and market the ensuing medicines. The company was founded in 2021 by Robert Vee-Lin Thong and Alasdair Thong, and Robert Vee-Lin Thong has been the CEO since 2021.

Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom.

Mubadala Infrastructure Partners Ltd. provides infrastructure investment and development services. The company is headquartered in St. Peter Port, the United Kingdom.

Curiosity Edtech Pte Ltd. is the Indian company behind CuriousJr, an online coding platform for kids. The company is based in Gurgaon, India. The platform offers an effective curriculum and practice modules to teach coding, which is considered an essential skill for the future. The company was founded by IITians with the aim of helping kids acquire future skills.

Ada Ventures LLP (Ada Ventures) is a venture capital firm founded in 2018. The firm was founded in 2018. The firm is headquartered in London, UK.

Exogene Ltd. develops an artificial intelligence machine learning platform to discover cell therapies for cancer immunotherapies. The company is based in Oxford, UK. The British company was founded by Andrea Mambrini and Federico Paoletti, with Federico Paoletti serving as CEO since incorporation.

Part of Sanome Ltd, Sanome operates as a British biotechnology company that develops at-home health monitoring tools. The company is based in Cambridge, UK. The company was founded by Benedikt von Thüngen, Marc Philippe Camille van der Schee. Benedikt von Thüngen has been the CEO since incorporation.

KdT Ventures LLC (KdT Ventures) is a venture capital firm founded in 2017 by Cain Mcclary . The firm is headquartered in Austin, Texas.

Avro Life Science develops skin patches for generic drug delivery. It focuses on children and adult therapeutics. The company was founded by Shakir Lakhani and Keean Sarani and is headquartered in Canada.

F-Star Biotechnology Ltd. is a biopharmaceutical company. It discovers, develops, and manufactures bispecific antibody products. The company is headquartered in Cambridge, the United Kingdom.

The University of Liverpool operates as a university. It offers post graduate research, foundation courses, continuing and professional development, online study, and doctoral college. The company was founded in 1881 and is headquartered in Liverpool, the United Kingdom.

Atlantic Healthcare Plc operates as holding company with interest in pharmaceutical. Its products include Alicaforsen Enema, an anti-inflammatory intercellular adhesion molecule inhibitor that acts by inhibiting a key protein in the inflammation process. The firm offers its product for the treatment of pouchitis and ulcerative colitis. The company was founded by Toby Wilson Waterworth and Fiona Mary Wilson Waterworth in 2006 and is headquartered in Saffron Walden, the United Kingdom.

Part of Pfizer Inc., Pfizer Holdings International Luxembourg (PHIL) SARL is an investment holding company. The company is based in Luxembourg, Luxembourg.

F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH develops improved therapeutic antibodies and antibody fragments for cancer. It is a biopharmaceutical company dedicated to developing novel bispecific antibody products that significantly improve on the current standard of care for patients with serious diseases such as cancer. The firm's modular antibody technology allows them to rapidly discover and develop bispecific antibodies by introducing additional binding sites to the constant region of an antibody. The company was founded by Florian Ruker, Gordana Wozniak-Knopp, and Gottfried Himmler on June 12, 2006 and is headquartered in Vienna, Austria.

Part of Sino Biopharmaceutical Ltd., F-Star Delta Ltd. develops antibody products to improve the treatment of serious diseases. The company is based in Cambridge, UK and was founded in 2016.

F-Star Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of immune-oncology drugs for antibody therapies. The company was founded in 2006 and is headquartered in Cambridge, the United Kingdom.

Avacta Life Sciences Ltd. provides powerful reagents for research and diagnostics. The company is headquartered in Wetherby, the United Kingdom.

F-star Alpha Ltd. develops novel bispecific antibody products. It focuses on treatment of breast and gastric cancer among a population of HER2-positive patients who do not respond or become resistant to current therapies. The company was founded in October 2013 and is headquartered in Cambridge, the United Kingdom.

F-Star Beta Ltd. is a biopharmaceutical company that focused in the development of oncology and immune-oncology products. The company was founded on October 14, 2014 and is headquartered in Cambridge, the United Kingdom.

Pioneer Fund/NY/ is a venture capital firm founded by Jason Gray. The firm is headquartered in San Francisco, California.